Primary central nervous system lymphoma: current state of anti-CD20 therapy and appraisal of reported response criteria.
about
Intraocular Lymphoma: Descriptive Data of 26 Patients Including Clinico-pathologic Features, Vitreous Findings, and Treatment Outcomes.Targeting CXCL13 During NeuroinflammationMethotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma.Immunotherapy with the trifunctional anti-CD20 × anti-CD3 antibody FBTA05 in a patient with relapsed t(8;14)-positive post-transplant lymphoproliferative disease.
P2860
Primary central nervous system lymphoma: current state of anti-CD20 therapy and appraisal of reported response criteria.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Primary central nervous system ...... of reported response criteria.
@en
type
label
Primary central nervous system ...... of reported response criteria.
@en
prefLabel
Primary central nervous system ...... of reported response criteria.
@en
P1476
Primary central nervous system ...... of reported response criteria.
@en
P2093
Tali Siegal
P304
P356
10.1016/J.JOCN.2014.02.002
P577
2014-05-01T00:00:00Z